Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Soland Insider Profile
11 Followers
Daniel Soland, Director at ACADIA Pharmaceuticals, holds 20.00K shares in DBV Technologies SA - American (Ticker: DBVT), holds 28.00K shares in ACADIA Pharmaceuticals (Ticker: ACAD), holds 78.84K shares in Aceragen (Ticker: ACGN). Most recently, Daniel Soland Bought ― shares of DBV Technologies SA - American on Aug 03, 2023 for an estimated value of 24.30K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-35.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Soland holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 02, 2018 - Mar 02, 2019
Return:+12.30%
The most profitable trade made by Daniel Soland
Daniel Soland's Trading History
ACADIA Pharmaceuticals
Jun 05, 2023
Director
Uninformative Buy
―
$468.75K
KalVista Pharmaceuticals
Sep 30, 2019
Director
Informative Buy
118.68K
$112.10K
Aceragen
Jun 21, 2021
―
Informative Buy
59.50K
$29.96K
DBV Technologies SA - American
Aug 03, 2023
Director
Informative Buy
24.30K
$13.60K
Viropharma
Jan 28, 2014
―
Uninformative Sell
7.67M
―
List of latest transactions for each holding click on a transaction to see Daniel Soland's performance on stock
You May Also Like
Daniel Soland insider profile FAQ
What is the percentage of profitable transactions made by Daniel Soland?
The percentage of profitable transactions made by Daniel Soland is 40%.
What is the average return per transaction made by Daniel Soland?
The average return per transaction made by Daniel Soland is -35.90%.
What stocks does Daniel Soland hold?
Daniel Soland holds: ACAD, KALV, ACGN, DBVT, VPHM stocks.
What was Daniel Soland’s latest transaction?
Daniel Soland latest transaction was an Informative Buy of $24.30K.
What was Daniel Soland's most profitable transaction?
Daniel Soland’s most profitable transaction was an Informative Buy of ACAD stock on March 2, 2018. The return on the trade was 12.30%.
What is Daniel Soland's role in ACADIA Pharmaceuticals?
Daniel Soland's role in ACADIA Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.